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PERSPECTIVE
Beyond DSM and ICD: introducing “precision
diagnosis” for psychiatry using momentary
assessment technology
JIM VAN OS1,2, PHILIPPE DELESPAUL1, JOHANNA WIGMAN1, INEZ MYIN-GERMEYS1, MARIEKE WICHERS1
1Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, 6200 MD Maastricht, the
Netherlands, 2Department of Psychosis Studies, Institute of Psychiatry, King’s College London, King’s Health Partners, De Crespigny Park, London SE5 8AF, UK
In medicine, a diagnostic system should ideally be mecha-
nism-based rather than symptom-based. Although attempts
to create diagnostic entities in psychiatry that are based on
specific biological mechanisms have failed (1), new evidence
suggests that an alternative mechanistic approach, based on
mental mechanisms, can be readily implemented in psychia-
try, complementing the widely criticized categorical systems
of DSM and ICD.
Below, we describe the contours of a novel system of
diagnosis in psychiatry based on: a) the need for a more
individualized approach, based on causal influences in
symptom circuits (“precision diagnosis”); b) the need to
take into account the fact that symptoms reflect responses
to context (“context diagnosis”); c) the need to take into
account that syndromes develop over time and have rec-
ognizable stages of expression (“staging diagnosis”) (2);
and d) the need for the diagnostic process to become col-
laborative rather than unidirectional, reflecting the first
stage of collaboration between patient and professional,
and the first stage of treatment.
The proposed diagnostic system is based on novel digital
momentary assessment technology, which allows the patient
to collect data on symptoms and contexts in the flow of daily
life, from which detailed contextual symptom circuits can be
constructed, that serve as a diagnostic and therapeutic tool,
as well as an instrument to assess change.
THE PRINCIPLE OF CONTEXTUAL PRECISION
DIAGNOSIS
The main problem with psychiatric diagnosis is that groups
identified by a common label, for example schizophrenia, in
fact have little in common. The level of heterogeneity in terms
of psychopathology, need for care, treatment response, illness
course, cognitive vulnerabilities, environmental exposures
and biological correlates is so great that it becomes implausi-
ble that these labels can provide much clinical utility.
In other areas of medicine, unexplained heterogeneity was
addressed by the introduction of precision (or personalized)
diagnosis. For example, blood pressure, plasma glucose, car-
diac rhythm, electroencephalogram, muscle tone and other
somatic outcomes can now be monitored in daily life, allow-
ing for a diagnosis that yields individualized information
about the pattern of variation of the parameter in question in
response to daily life circumstances. This diagnostic informa-
tion is precise, as it reflects highly personal patterns of varia-
tion, and is contextual, as it traces variation related to daily
life circumstances of, for example, stress, sleep, medication
and life style. It is also collaborative, as the patient is actively
involved in collecting and interpreting the diagnostic data.
This not only enables precise indexing of treatment needs (di-
agnosis), but also precise monitoring of treatment response
(prognosis). A similar system of contextual precision diagno-
sis may be useful in psychiatry.
PRECISION: DIAGNOSING MENTAL CAUSATION
IN SYMPTOM CIRCUITS
How can diagnosis based on psychopathology be similarly
individualized? To date, the most commonly used attempt at
individualization is based on assigning individuals to diag-
nostic categories, in combination with personalized ratings
of psychopathology across different dimensions. In theory,
this system of “dimensionalized categories” ought to yield ac-
ceptable precision, given that two individuals within the
same diagnostic category will nearly always have different
psychopathological profiles.
Recent research, however, indicates that this system is
based on the false premise that symptoms always vary to-
gether as a function of a latent underlying dimension or cate-
gory – which does not appear to be the case (3,4). Instead, it
has been argued that mental “disorders” in fact may repre-
sent sets of symptoms that are connected through a system
of causal relations, which may explain individualized co-
occurrence of different symptoms (4,5). For example, the
negative and positive symptoms of schizophrenia have
largely independent courses (6), and etiological factors
appear to operate at the symptom level rather than the diag-
nostic disorder level (7-9).
Therefore, there is increasing interest in how multiple
symptoms in individuals arise not as a function of a latent
construct, but as a function of symptoms impacting on each
other, for example insomnia impacting on depressive symp-
toms (10) or on paranoia (11), depressive symptoms impact-
ing on anxiety symptoms (12), affective disturbance giving
rise to psychosis (13,14), negative symptoms predicting psy-
chosis (15), and hallucinations impacting on delusions
(16,17). Not only between-symptom dynamic relationships
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have been described, but intra-symptom temporal dynamics
resulting in persistence or, in momentary assessment tech-
nology terms, momentary transfer of symptoms have been
observed. For example, intra-symptom dynamics over time,
in the form of intra-symptom feedback loops, have been
described in the area of psychosis, both at the momentary
“micro-level” over the course of a single day in daily life
(18), or over the course of months or years (19,20), under
the influence of genetic and non-genetic risk factors (21-23).
The notion that traditional diagnostic categories and
dimensions need to be transformed to represent the dy-
namics of symptoms impacting on each other over time in
a model of mental mechanisms or mental causation is tan-
talizing. It implies that special methodology is required to
collect repeated measures of symptoms over time in the
flow of daily life, both at the momentary level and over
more extended periods (24). This type of information
allows for a detailed analysis and systematic presentation
(25) of how symptoms impact each other (4,5,18).
CONTEXT: DIAGNOSING ENVIRONMENTAL
REACTIVITY
Although it is widely believed that mental disorders have
their origin in altered cerebral function, disease categories
as defined in DSM and ICD do not map on to what the brain
actually does: mediating the continuous flow of meaningful
perceptions of the social environment that guide adaptive
behaviour. The use of ex-cathedra static diagnostic catego-
ries appears distal from the neural circuits that mediate
dynamic adaptation to social context.
Therefore, reformulation of the basic psychopathological
unit towards capturing dynamic reactivity, modelled on the
role of neural circuits in mediating adaptive functioning to
social context, may be productive in the context of diagno-
sis. Momentary assessment technology phenotypes captur-
ing dimensional variation in mental states in response to
other mental states in the symptom circuit on the one
hand, and to environmental variation on the other, are well
placed to fill these requirements (Figure 1), resulting in a di-
agnosis that is both contextual and precise.
It is proposed that momentary assessments of contex-
tual symptom circuits, using the Experience Sampling
Method (ESM), will provide a fertile model for investiga-
tion of psychopathology, encompassing phenotypes at
multiple levels of neurofunctional organization (26). For
example, momentary assessment technology studies of ex-
posure to early trauma in humans have yielded replicated
evidence that early environmental exposures predict
altered momentary response to stress in adulthood that
increase the risk of mental disorder (27-29). There is a
Figure 1 Momentary assessment with the Experience Sampling Method (ESM). At 10 random moments during the day, mental states (e.g.,
anxiety, low mood, paranoia, being happy) and contexts (stress, company, activity, drug use) are assessed. The arrows represent examples of
prospectively analyzing the impact of mental states and contexts on each other over time.
114 World Psychiatry 12:2 - June 2013
suggestion that these ESM phenotypes of behavioural
sensitization (30) can be linked to biological models of
sensitization (31,32), thus suggesting that the momentary
environmental reactivity may represent a key variable in
linking mental and neurobiological phenotypes (33). Also,
several ESM mental state measures have shown that con-
nections between momentary mental states and environ-
ments are sensitive to genetic effects, not just in terms of
heritability and familial resemblance (34,35), but particu-
larly in terms of the genetics underlying environmental
sensitivity (36-43), a mechanism referred to as gene-envi-
ronment interaction.
EMPOWERMENT: A COLLABORATIVE DIAGNOSTIC
PROCESS
In the momentary assessment paradigm of diagnosis as
described above, patients collect their own data in daily
life, and not only assist in observing variation in mental
states, but also learn about daily environments likely to
induce changes therein. Their experiences are assessed and
translated in the diagnostic paradigm. For example, track-
ing aberrant salience can be explained as “let’s follow how
you tend to put some issues under a magnifying glass”, or
“let’s see what kind of environment helps you to generate
positive affect”. This stimulates awareness and involves
patients in making their own diagnosis, both at the level of
psychopathology and at the level of functioning, relevant
for both treatment and rehabilitation. During treatment,
patients can directly observe how treatment impacts their
dynamically varying mental states in response to environ-
mental challenges in the flow of daily life. Patients thus
become empowered to evaluate their own diagnosis and
treatments in daily life, outside the doctor’s office. Doctors,
in turn, are given access to a much more accurate, prospec-
tive measurement of the phenotype of mental disorder:
rather than a static cross-sectional measure that is not rep-
resentative of what the patient experiences outside the doc-
tor’s office, they now have access to the true phenotype of
continuous and dynamic variation in response to environ-
mental challenges in the flow of daily life, allowing them to
not only prescribe treatments, but also life style alterations
targeting challenging environments.
PRECISION DIAGNOSIS IN CLINICAL PRACTICE
An example of contextual precision diagnosis is depicted
in Figure 2. “Diagnosis” here refers to the visual display of
causal relationships between symptoms and environment (in
the example: stress) in the circuit. The circuit not only focuses
on environment and symptoms, but also includes positive
affective states, thus increasing therapeutic relevance.
Previous work has shown that contextual precision
diagnosis is highly sensitive to longitudinal development
of phenotypes across definable stages; in that connection
strength and connection variability between mental states
differ in a predictable fashion across different stages of
psychopathology (44). In addition, there is evidence that
symptom circuit dynamics based on momentary assess-
ment technology is sensitive to genetic variation and neu-
ral function (45-47), and can be used to predict dynamic
transitions from a state of vulnerability to illness (48).
Contextual precision diagnosis is idiographic and sensi-
tive to stages of psychopathology, replacing the need for
nomothetic approaches that lack validity and practical
utility (49). Finally, there is emerging evidence that the
process of contextual precision diagnosis using ESM has
therapeutic effects by itself (50-52).
CONCLUSIONS
Although it may be useful to retain some of the higher
order syndromal groupings, such as common mental disor-
der and severe mental disorder, the focus of contextual preci-
sion diagnosis is on the individual, neutralizing the forces
of stereotyping and treatment irrelevance. The summary
Figure 2 Contextual precision diagnosis. Thicker lines indicate stron-
ger associations. The (simulated) patient in this example did 6 days of
experience sampling in order to determine circuit patterns of stress
and mutually impacting mental states. The resulting causal circuit is
depicted. A strong positive (black lines) feedback loop exists between
positive states (relaxed and cheerful) and a negative (dotted grey
lines) feedback loop exists between the opposite mental states of
being cheerful and being paranoid. Stress occasions paranoia and
impacts negatively on cheerfulness. Being relaxed helps reducing low
mood and anxiety. Both cheerfulness and paranoia have a strong
tendency to persist over time, increasing he probability of stable
symptoms (18).
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presented above suggests that novel momentary assessment
diagnostic systems delivering patient- and treatment-relevant
information represent a welcome addition to the diagnostic
toolbox in psychiatry.
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